Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Generic Drugs
Par Pharmaceutical begins shipment of generic Glucovance tablets
May 31st, 2004
Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc., (PRX), announced that it has commenced shipment of substitutable generic glyburide and metformin hydrochloride (HCl) tablets. Glyburide and metformin HCl is the generic version of Bristol-Myers Squibb Co.'s Glucovance tablets. Glucovance combines these two widely prescribed oral antidiabetic agents in a single pill. Glucovance is used in the treatment of type 2 diabetes and has annual U.S. sales of approximately $500 million. "We are very pleased to collaborate once again with Genpharm and Bristol-Myers Squibb," said Scott Tarriff, president and...
Source: Obesity & Diabetes Week (2004-05-31)
|
